Enhabit, Inc. (EHAB)
(Delayed Data from NYSE)
$8.95 USD
-0.45 (-4.79%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $8.94 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EHAB 8.95 -0.45(-4.79%)
Will EHAB be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for EHAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EHAB
Enhabit (EHAB) Beats Q1 Earnings Estimates
Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
EHAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enhabit (EHAB) Lags Q3 Earnings and Revenue Estimates
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
Analysts Estimate Enhabit (EHAB) to Report a Decline in Earnings: What to Look Out for
Other News for EHAB
Enhabit Home Health & Hospice Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For
Enhabit Executives Speak at Goldman Sachs Healthcare Conference
Enhabit Details Decisive Actions to Successfully Stabilize Business and Position Company for Value Creation
Enhabit files definitive proxy materials and mails letter to stockholders
AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Changes to Board Composition